|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Federal funds sold and securities purchased under resale agreements or similar arrangements | ||||||||||||||||||||
| Investment securities: | ||||||||||||||||||||
| AFS at fair value (amortized cost of $7,426,314 and $7,956,281 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Trading securities | ||||||||||||||||||||
| HTM (fair value of $11,548,907 and $11,871,362 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| LHFI | ||||||||||||||||||||
| ALLL | ||||||||||||||||||||
| Net LHFI | ||||||||||||||||||||
| LHFS | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating lease assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| BOLI | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Accounts payables and accrued expenses | ||||||||||||||||||||
| Deposits and other customer accounts | ||||||||||||||||||||
| Federal funds purchased and securities loaned or sold under repurchase agreements | ||||||||||||||||||||
| Trading liabilities | ||||||||||||||||||||
| Borrowings and other debt obligations | ||||||||||||||||||||
| Advance payments by borrowers for taxes and insurance | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| MEZZANINE EQUITY | ||||||||||||||||||||
| Preferred stock (no par value; 7,500,000 shares authorized; 2,000,000 shares outstanding at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| STOCKHOLDER'S EQUITY | ||||||||||||||||||||
| Common stock and paid-in capital (no par value; 800,000,000 shares authorized; 530,391,043 shares outstanding at both June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDER'S EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDER'S EQUITY | ||||||||||||||||||||
Loading...
